Covetrus reports gain in sales for Q1, smaller loss over 2020

Portland-based Covetrus Inc. (Nasdaq: CVET) on Thursday reported an increase in net sales during this year’s first quarter of $1.1 billion, an increase of 3% compared to the first quarter of 2020.

But the company reported a net loss for Q1 this year of $16 million, or 11 cents per diluted share, which compared to a net loss in Q1 2020 of $33 million, or 30 cents.

“The team delivered a strong start to 2021 and added strength to our foundation with healthy and profitable growth across each of the company’s segments,” Ben Wolin, president and CEO of the animal-health technology and services company, said in a news release. Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024